HEADER SIGNALING PROTEIN 28-MAR-16 5J11 TITLE STRUCTURE OF HUMAN TSLP IN COMPLEX WITH TSLPR AND IL-7RALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIC STROMAL LYMPHOPOIETIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: BEFORE CRYSTALLISATION, THE N-TERMINAL HIS-TAG COMPND 7 (RESIDUES 1 - 17, MGSSHHHHHHSSGLVPR) WAS REMOVED BY THROMBIN COMPND 8 CLEAVAGE. RESIDUES 127 TO 131 OF TSLP (127-RRKRK-131) (ACCORDING TO COMPND 9 THE REFERENCE SEQUENCE NUMBERING SCHEME FOR TSLP) WERE DELETED IN THE COMPND 10 CONSTRUCT USED FOR CRYSTALLIZATION.; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: INTERLEUKIN-7 RECEPTOR SUBUNIT ALPHA; COMPND 13 CHAIN: B; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: BEFORE CRYSTALLISATION, THE N-TERMINAL HIS-TAG COMPND 16 (RESIDUES 1 - 17, MGSSHHHHHHSSGLVPR) WAS REMOVED BY THROMBIN COMPND 17 CLEAVAGE.; COMPND 18 MOL_ID: 3; COMPND 19 MOLECULE: CYTOKINE RECEPTOR-LIKE FACTOR 2; COMPND 20 CHAIN: C; COMPND 21 SYNONYM: CYTOKINE RECEPTOR-LIKE 2,IL-XR,THYMIC STROMAL LYMPHOPOIETIN COMPND 22 PROTEIN RECEPTOR,TSLP RECEPTOR; COMPND 23 ENGINEERED: YES; COMPND 24 MUTATION: YES; COMPND 25 OTHER_DETAILS: THE SIGNAL PEPTIDE (RESIDUES 1 - 24) IS REMOVED FROM COMPND 26 THE MATURE PROTEIN. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TSLP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B-HTSLPDELTA127-131; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: IL7R; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B-HIL7RALPHA; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: CRLF2, CRL2, ILXR, TSLPR; SOURCE 24 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 25 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM_CELL_LINE: HEK293S MGAT1-/-; SOURCE 28 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PCDNA4/TO-HTSLPR-N47Q-HIS KEYWDS CYTOKINE INFLAMMATION TSLP SIGNALING COMPLEX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.VERSTRAETE,S.N.SAVVIDES REVDAT 5 10-JAN-24 5J11 1 HETSYN REVDAT 4 29-JUL-20 5J11 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 28-FEB-18 5J11 1 SOURCE REVDAT 2 19-APR-17 5J11 1 JRNL REVDAT 1 05-APR-17 5J11 0 JRNL AUTH K.VERSTRAETE,F.PEELMAN,H.BRAUN,J.LOPEZ,D.VAN ROMPAEY, JRNL AUTH 2 A.DANSERCOER,I.VANDENBERGHE,K.PAUWELS,J.TAVERNIER, JRNL AUTH 3 B.N.LAMBRECHT,H.HAMMAD,H.DE WINTER,R.BEYAERT,G.LIPPENS, JRNL AUTH 4 S.N.SAVVIDES JRNL TITL STRUCTURE AND ANTAGONISM OF THE RECEPTOR COMPLEX MEDIATED BY JRNL TITL 2 HUMAN TSLP IN ALLERGY AND ASTHMA. JRNL REF NAT COMMUN V. 8 14937 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 28368013 JRNL DOI 10.1038/NCOMMS14937 REMARK 2 REMARK 2 RESOLUTION. 2.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 24638 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1238 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.56 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2738 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2708 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2600 REMARK 3 BIN R VALUE (WORKING SET) : 0.2674 REMARK 3 BIN FREE R VALUE : 0.3351 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.04 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3966 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 69.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 88.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.25510 REMARK 3 B22 (A**2) : -2.53360 REMARK 3 B33 (A**2) : -6.72160 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 12.68440 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.328 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.319 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7863 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 14104 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1679 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 92 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1172 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7863 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 549 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7975 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.73 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 290.2639 41.9113 36.0957 REMARK 3 T TENSOR REMARK 3 T11: -0.3384 T22: -0.0024 REMARK 3 T33: -0.0399 T12: -0.0433 REMARK 3 T13: 0.0083 T23: -0.0301 REMARK 3 L TENSOR REMARK 3 L11: 4.4446 L22: 5.6989 REMARK 3 L33: 1.7977 L12: 1.1750 REMARK 3 L13: -1.0264 L23: -0.6780 REMARK 3 S TENSOR REMARK 3 S11: -0.0655 S12: -0.0246 S13: -0.4846 REMARK 3 S21: 0.0250 S22: -0.1559 S23: -0.7321 REMARK 3 S31: 0.0314 S32: 0.3730 S33: 0.2214 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|37 - B|124 } REMARK 3 ORIGIN FOR THE GROUP (A): 303.2780 62.9087 19.9274 REMARK 3 T TENSOR REMARK 3 T11: -0.2394 T22: 0.0896 REMARK 3 T33: -0.0825 T12: -0.2753 REMARK 3 T13: -0.0120 T23: 0.3058 REMARK 3 L TENSOR REMARK 3 L11: 4.1153 L22: 3.3084 REMARK 3 L33: 2.8863 L12: 0.5540 REMARK 3 L13: -0.5053 L23: -1.1489 REMARK 3 S TENSOR REMARK 3 S11: -0.1490 S12: 0.3705 S13: 0.2808 REMARK 3 S21: -0.3638 S22: -0.5690 S23: -1.1066 REMARK 3 S31: -0.5998 S32: 1.0122 S33: 0.7180 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { B|125 - B|231 } REMARK 3 ORIGIN FOR THE GROUP (A): 274.2528 68.4888 13.6108 REMARK 3 T TENSOR REMARK 3 T11: 0.1946 T22: -0.1610 REMARK 3 T33: -0.3280 T12: 0.0294 REMARK 3 T13: -0.1174 T23: -0.0794 REMARK 3 L TENSOR REMARK 3 L11: 3.7777 L22: 2.2414 REMARK 3 L33: 2.9168 L12: -1.4467 REMARK 3 L13: 2.0061 L23: -1.6471 REMARK 3 S TENSOR REMARK 3 S11: -0.1676 S12: 0.1014 S13: 0.0560 REMARK 3 S21: -0.0009 S22: -0.0381 S23: 0.2181 REMARK 3 S31: -0.8161 S32: 0.0138 S33: 0.2057 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { C|29 - C|114 C|500} REMARK 3 ORIGIN FOR THE GROUP (A): 267.4400 25.6685 39.5052 REMARK 3 T TENSOR REMARK 3 T11: -0.3162 T22: -0.1791 REMARK 3 T33: 0.0929 T12: 0.0153 REMARK 3 T13: -0.0137 T23: -0.1233 REMARK 3 L TENSOR REMARK 3 L11: 4.1416 L22: 5.5834 REMARK 3 L33: 2.6763 L12: -0.3469 REMARK 3 L13: -0.1319 L23: -1.7209 REMARK 3 S TENSOR REMARK 3 S11: 0.0999 S12: 0.1860 S13: -0.8700 REMARK 3 S21: -0.4587 S22: -0.0589 S23: 0.2342 REMARK 3 S31: 0.3064 S32: 0.0917 S33: -0.0410 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: { C|115 - C|219 C|501} REMARK 3 ORIGIN FOR THE GROUP (A): 260.8787 56.3000 28.2342 REMARK 3 T TENSOR REMARK 3 T11: -0.0909 T22: -0.1282 REMARK 3 T33: -0.1312 T12: 0.1486 REMARK 3 T13: 0.0082 T23: -0.1158 REMARK 3 L TENSOR REMARK 3 L11: 3.0353 L22: 6.8271 REMARK 3 L33: 4.2026 L12: -2.5347 REMARK 3 L13: 2.0232 L23: -3.1702 REMARK 3 S TENSOR REMARK 3 S11: -0.0851 S12: 0.0906 S13: 0.1471 REMARK 3 S21: 0.1256 S22: 0.1465 S23: 0.6906 REMARK 3 S31: -1.1017 S32: -0.4863 S33: -0.0614 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J11 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219512. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9801 REMARK 200 MONOCHROMATOR : SI[111] REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION NOVEMBER 3, 2014 REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24638 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.560 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: X-RAY STRUCTURE OF HUMAN TSLP IN COMPLEX WITH REMARK 200 HUMAN TSLPR AND MOUSE IL-7RALPHA; PDB 3DI2: CHAIN B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.02 M CITRIC ACID 0.08 M BIS-TRIS REMARK 280 PROPANE 16% W/V POLYETHYLENE GLYCOL 3350, PH 8.8, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.89150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.32200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.89150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 33.32200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 SER A 11 REMARK 465 HIS A 12 REMARK 465 HIS A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 SER A 18 REMARK 465 SER A 19 REMARK 465 GLY A 20 REMARK 465 LEU A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 ARG A 24 REMARK 465 GLY A 25 REMARK 465 SER A 26 REMARK 465 HIS A 27 REMARK 465 THR A 121 REMARK 465 GLN A 122 REMARK 465 ILE A 123 REMARK 465 ASN A 124 REMARK 465 ALA A 125 REMARK 465 THR A 126 REMARK 465 GLN A 127 REMARK 465 ALA A 128 REMARK 465 MET A 129 REMARK 465 LYS A 130 REMARK 465 LYS A 131 REMARK 465 VAL A 132 REMARK 465 THR A 133 REMARK 465 MET B 0 REMARK 465 GLY B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 HIS B 4 REMARK 465 HIS B 5 REMARK 465 HIS B 6 REMARK 465 HIS B 7 REMARK 465 HIS B 8 REMARK 465 HIS B 9 REMARK 465 SER B 10 REMARK 465 SER B 11 REMARK 465 GLY B 12 REMARK 465 LEU B 13 REMARK 465 VAL B 14 REMARK 465 PRO B 15 REMARK 465 ARG B 16 REMARK 465 GLY B 17 REMARK 465 SER B 18 REMARK 465 HIS B 19 REMARK 465 MET B 20 REMARK 465 GLU B 21 REMARK 465 SER B 22 REMARK 465 GLY B 23 REMARK 465 TYR B 24 REMARK 465 ALA B 25 REMARK 465 GLN B 26 REMARK 465 ASN B 27 REMARK 465 GLY B 28 REMARK 465 ASP B 29 REMARK 465 LEU B 30 REMARK 465 GLU B 31 REMARK 465 ASP B 32 REMARK 465 ALA B 33 REMARK 465 GLU B 34 REMARK 465 LEU B 35 REMARK 465 ASP B 36 REMARK 465 ASN B 233 REMARK 465 SER B 234 REMARK 465 SER B 235 REMARK 465 GLY B 236 REMARK 465 GLU B 237 REMARK 465 MET B 238 REMARK 465 ASP B 239 REMARK 465 MET C 1 REMARK 465 GLY C 2 REMARK 465 ARG C 3 REMARK 465 LEU C 4 REMARK 465 VAL C 5 REMARK 465 LEU C 6 REMARK 465 LEU C 7 REMARK 465 TRP C 8 REMARK 465 GLY C 9 REMARK 465 ALA C 10 REMARK 465 ALA C 11 REMARK 465 VAL C 12 REMARK 465 PHE C 13 REMARK 465 LEU C 14 REMARK 465 LEU C 15 REMARK 465 GLY C 16 REMARK 465 GLY C 17 REMARK 465 TRP C 18 REMARK 465 MET C 19 REMARK 465 ALA C 20 REMARK 465 LEU C 21 REMARK 465 GLY C 22 REMARK 465 GLN C 23 REMARK 465 GLY C 24 REMARK 465 GLY C 25 REMARK 465 ALA C 26 REMARK 465 ALA C 27 REMARK 465 GLU C 28 REMARK 465 ALA C 219 REMARK 465 GLU C 220 REMARK 465 THR C 221 REMARK 465 GLY C 222 REMARK 465 THR C 223 REMARK 465 LYS C 224 REMARK 465 HIS C 225 REMARK 465 HIS C 226 REMARK 465 HIS C 227 REMARK 465 HIS C 228 REMARK 465 HIS C 229 REMARK 465 HIS C 230 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 28 CG SD CE REMARK 470 LYS A 59 CD CE NZ REMARK 470 GLU A 62 CG CD OE1 OE2 REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 THR A 134 OG1 CG2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 GLN A 159 CG CD OE1 NE2 REMARK 470 ASP B 37 CG OD1 OD2 REMARK 470 ASP B 63 CG OD1 OD2 REMARK 470 ASN B 65 CG OD1 ND2 REMARK 470 THR B 67 OG1 CG2 REMARK 470 ASN B 68 CG OD1 ND2 REMARK 470 GLU B 70 CG CD OE1 OE2 REMARK 470 LYS B 87 CG CD CE NZ REMARK 470 VAL B 111 CG1 CG2 REMARK 470 GLU B 113 CG CD OE1 OE2 REMARK 470 LYS B 114 CD CE NZ REMARK 470 LEU B 116 CG CD1 CD2 REMARK 470 LYS B 120 CD CE NZ REMARK 470 GLU B 141 CG CD OE1 OE2 REMARK 470 LYS B 173 CG CD CE NZ REMARK 470 GLU B 175 CG CD OE1 OE2 REMARK 470 ASN B 176 CG OD1 ND2 REMARK 470 LYS B 177 CG CD CE NZ REMARK 470 GLU B 230 CG CD OE1 OE2 REMARK 470 ILE B 231 CG1 CG2 CD1 REMARK 470 ASN B 232 CG OD1 ND2 REMARK 470 LYS C 50 CE NZ REMARK 470 ARG C 53 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 131 CG CD OE1 NE2 REMARK 470 GLU C 178 CG CD OE1 OE2 REMARK 470 GLU C 205 CG CD OE1 OE2 REMARK 470 GLU C 213 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 31 39.04 -93.26 REMARK 500 THR A 46 -31.34 -139.01 REMARK 500 SER A 70 -92.09 -105.00 REMARK 500 TYR B 38 41.08 -98.70 REMARK 500 GLN B 89 -123.12 49.50 REMARK 500 GLU B 90 36.29 -99.70 REMARK 500 TYR B 159 -75.19 -82.66 REMARK 500 GLU B 175 -84.94 -97.09 REMARK 500 LYS B 177 49.55 -100.70 REMARK 500 HIS B 211 78.31 71.73 REMARK 500 ASN C 38 29.47 49.13 REMARK 500 ALA C 48 95.32 -162.56 REMARK 500 TYR C 51 41.98 -94.53 REMARK 500 GLN C 131 -106.71 53.79 REMARK 500 ASP C 132 47.87 -108.10 REMARK 500 ASN C 169 86.65 -163.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR C 60 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 5J11 A 29 159 UNP Q969D9 TSLP_HUMAN 29 159 DBREF 5J11 B 21 236 UNP D6RGV2 D6RGV2_HUMAN 21 236 DBREF 5J11 C 1 221 UNP Q9HC73 CRLF2_HUMAN 1 221 SEQADV 5J11 MET A 8 UNP Q969D9 INITIATING METHIONINE SEQADV 5J11 GLY A 9 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 SER A 10 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 SER A 11 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 12 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 13 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 14 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 15 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 16 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 17 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 SER A 18 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 SER A 19 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 GLY A 20 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 LEU A 21 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 VAL A 22 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 PRO A 23 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 ARG A 24 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 GLY A 25 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 SER A 26 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 HIS A 27 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 MET A 28 UNP Q969D9 EXPRESSION TAG SEQADV 5J11 A UNP Q969D9 LYS 126 DELETION SEQADV 5J11 A UNP Q969D9 ARG 127 DELETION SEQADV 5J11 A UNP Q969D9 ARG 128 DELETION SEQADV 5J11 A UNP Q969D9 LYS 129 DELETION SEQADV 5J11 A UNP Q969D9 ARG 130 DELETION SEQADV 5J11 MET B 0 UNP D6RGV2 INITIATING METHIONINE SEQADV 5J11 GLY B 1 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 SER B 2 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 SER B 3 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 4 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 5 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 6 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 7 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 8 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 9 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 SER B 10 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 SER B 11 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 GLY B 12 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 LEU B 13 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 VAL B 14 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 PRO B 15 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 ARG B 16 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 GLY B 17 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 SER B 18 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 HIS B 19 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 MET B 20 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 GLU B 237 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 MET B 238 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 ASP B 239 UNP D6RGV2 EXPRESSION TAG SEQADV 5J11 GLN C 47 UNP Q9HC73 ASN 47 CONFLICT SEQADV 5J11 GLY C 222 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 THR C 223 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 LYS C 224 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 225 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 226 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 227 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 228 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 229 UNP Q9HC73 EXPRESSION TAG SEQADV 5J11 HIS C 230 UNP Q9HC73 EXPRESSION TAG SEQRES 1 A 147 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 147 LEU VAL PRO ARG GLY SER HIS MET TYR ASP PHE THR ASN SEQRES 3 A 147 CYS ASP PHE GLU LYS ILE LYS ALA ALA TYR LEU SER THR SEQRES 4 A 147 ILE SER LYS ASP LEU ILE THR TYR MET SER GLY THR LYS SEQRES 5 A 147 SER THR GLU PHE ASN ASN THR VAL SER CYS SER ASN ARG SEQRES 6 A 147 PRO HIS CYS LEU THR GLU ILE GLN SER LEU THR PHE ASN SEQRES 7 A 147 PRO THR ALA GLY CYS ALA SER LEU ALA LYS GLU MET PHE SEQRES 8 A 147 ALA MET LYS THR LYS ALA ALA LEU ALA ILE TRP CYS PRO SEQRES 9 A 147 GLY TYR SER GLU THR GLN ILE ASN ALA THR GLN ALA MET SEQRES 10 A 147 LYS LYS VAL THR THR ASN LYS CYS LEU GLU GLN VAL SER SEQRES 11 A 147 GLN LEU GLN GLY LEU TRP ARG ARG PHE ASN ARG PRO LEU SEQRES 12 A 147 LEU LYS GLN GLN SEQRES 1 B 240 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 240 LEU VAL PRO ARG GLY SER HIS MET GLU SER GLY TYR ALA SEQRES 3 B 240 GLN ASN GLY ASP LEU GLU ASP ALA GLU LEU ASP ASP TYR SEQRES 4 B 240 SER PHE SER CYS TYR SER GLN LEU GLU VAL ASN GLY SER SEQRES 5 B 240 GLN HIS SER LEU THR CYS ALA PHE GLU ASP PRO ASP VAL SEQRES 6 B 240 ASN ILE THR ASN LEU GLU PHE GLU ILE CYS GLY ALA LEU SEQRES 7 B 240 VAL GLU VAL LYS CYS LEU ASN PHE ARG LYS LEU GLN GLU SEQRES 8 B 240 ILE TYR PHE ILE GLU THR LYS LYS PHE LEU LEU ILE GLY SEQRES 9 B 240 LYS SER ASN ILE CYS VAL LYS VAL GLY GLU LYS SER LEU SEQRES 10 B 240 THR CYS LYS LYS ILE ASP LEU THR THR ILE VAL LYS PRO SEQRES 11 B 240 GLU ALA PRO PHE ASP LEU SER VAL VAL TYR ARG GLU GLY SEQRES 12 B 240 ALA ASN ASP PHE VAL VAL THR PHE ASN THR SER HIS LEU SEQRES 13 B 240 GLN LYS LYS TYR VAL LYS VAL LEU MET HIS ASP VAL ALA SEQRES 14 B 240 TYR ARG GLN GLU LYS ASP GLU ASN LYS TRP THR HIS VAL SEQRES 15 B 240 ASN LEU SER SER THR LYS LEU THR LEU LEU GLN ARG LYS SEQRES 16 B 240 LEU GLN PRO ALA ALA MET TYR GLU ILE LYS VAL ARG SER SEQRES 17 B 240 ILE PRO ASP HIS TYR PHE LYS GLY PHE TRP SER GLU TRP SEQRES 18 B 240 SER PRO SER TYR TYR PHE ARG THR PRO GLU ILE ASN ASN SEQRES 19 B 240 SER SER GLY GLU MET ASP SEQRES 1 C 230 MET GLY ARG LEU VAL LEU LEU TRP GLY ALA ALA VAL PHE SEQRES 2 C 230 LEU LEU GLY GLY TRP MET ALA LEU GLY GLN GLY GLY ALA SEQRES 3 C 230 ALA GLU GLY VAL GLN ILE GLN ILE ILE TYR PHE ASN LEU SEQRES 4 C 230 GLU THR VAL GLN VAL THR TRP GLN ALA SER LYS TYR SER SEQRES 5 C 230 ARG THR ASN LEU THR PHE HIS TYR ARG PHE ASN GLY ASP SEQRES 6 C 230 GLU ALA TYR ASP GLN CYS THR ASN TYR LEU LEU GLN GLU SEQRES 7 C 230 GLY HIS THR SER GLY CYS LEU LEU ASP ALA GLU GLN ARG SEQRES 8 C 230 ASP ASP ILE LEU TYR PHE SER ILE ARG ASN GLY THR HIS SEQRES 9 C 230 PRO VAL PHE THR ALA SER ARG TRP MET VAL TYR TYR LEU SEQRES 10 C 230 LYS PRO SER SER PRO LYS HIS VAL ARG PHE SER TRP HIS SEQRES 11 C 230 GLN ASP ALA VAL THR VAL THR CYS SER ASP LEU SER TYR SEQRES 12 C 230 GLY ASP LEU LEU TYR GLU VAL GLN TYR ARG SER PRO PHE SEQRES 13 C 230 ASP THR GLU TRP GLN SER LYS GLN GLU ASN THR CYS ASN SEQRES 14 C 230 VAL THR ILE GLU GLY LEU ASP ALA GLU LYS CYS TYR SER SEQRES 15 C 230 PHE TRP VAL ARG VAL LYS ALA MET GLU ASP VAL TYR GLY SEQRES 16 C 230 PRO ASP THR TYR PRO SER ASP TRP SER GLU VAL THR CYS SEQRES 17 C 230 TRP GLN ARG GLY GLU ILE ARG ASP ALA CYS ALA GLU THR SEQRES 18 C 230 GLY THR LYS HIS HIS HIS HIS HIS HIS HET PGE C 301 24 HET NAG C 302 27 HET NAG C 303 27 HETNAM PGE TRIETHYLENE GLYCOL HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 PGE C6 H14 O4 FORMUL 5 NAG 2(C8 H15 N O6) FORMUL 7 HOH *29(H2 O) HELIX 1 AA1 ASP A 30 CYS A 34 5 5 HELIX 2 AA2 ASP A 35 THR A 46 1 12 HELIX 3 AA3 THR A 46 SER A 56 1 11 HELIX 4 AA4 LYS A 59 PHE A 63 5 5 HELIX 5 AA5 ASN A 71 ASN A 85 1 15 HELIX 6 AA6 GLU A 96 CYS A 110 1 15 HELIX 7 AA7 LYS A 136 ASN A 152 1 17 HELIX 8 AA8 ASP B 122 ILE B 126 5 5 HELIX 9 AA9 THR B 152 LYS B 157 5 6 HELIX 10 AB1 ARG B 193 LEU B 195 5 3 HELIX 11 AB2 ALA C 48 SER C 52 5 5 HELIX 12 AB3 MET C 190 GLY C 195 1 6 SHEET 1 AA1 4 PHE B 40 ASN B 49 0 SHEET 2 AA1 4 GLN B 52 PHE B 59 -1 O THR B 56 N TYR B 43 SHEET 3 AA1 4 ILE B 91 THR B 96 -1 O TYR B 92 N CYS B 57 SHEET 4 AA1 4 ARG B 86 LEU B 88 -1 N ARG B 86 O PHE B 93 SHEET 1 AA2 4 CYS B 82 ASN B 84 0 SHEET 2 AA2 4 GLU B 70 CYS B 74 -1 N ILE B 73 O LEU B 83 SHEET 3 AA2 4 SER B 105 VAL B 111 -1 O LYS B 110 N GLU B 70 SHEET 4 AA2 4 LYS B 114 ILE B 121 -1 O LYS B 119 N ILE B 107 SHEET 1 AA3 3 PHE B 133 ARG B 140 0 SHEET 2 AA3 3 ASP B 145 ASN B 151 -1 O ASN B 151 N PHE B 133 SHEET 3 AA3 3 LYS B 187 LEU B 191 -1 O LEU B 188 N VAL B 148 SHEET 1 AA4 4 THR B 179 LEU B 183 0 SHEET 2 AA4 4 LEU B 163 GLN B 171 -1 N TYR B 169 O THR B 179 SHEET 3 AA4 4 MET B 200 PRO B 209 -1 O ARG B 206 N ASP B 166 SHEET 4 AA4 4 TYR B 224 ARG B 227 -1 O PHE B 226 N TYR B 201 SHEET 1 AA5 5 TYR C 74 GLN C 77 0 SHEET 2 AA5 5 HIS C 80 ASP C 87 -1 O SER C 82 N LEU C 75 SHEET 3 AA5 5 THR C 41 GLN C 47 -1 N VAL C 42 O LEU C 86 SHEET 4 AA5 5 GLN C 31 PHE C 37 -1 N PHE C 37 O THR C 41 SHEET 5 AA5 5 LEU C 117 LYS C 118 1 O LYS C 118 N TYR C 36 SHEET 1 AA6 4 ASP C 69 GLN C 70 0 SHEET 2 AA6 4 THR C 57 ARG C 61 -1 N TYR C 60 O ASP C 69 SHEET 3 AA6 4 ILE C 94 ASN C 101 -1 O TYR C 96 N ARG C 61 SHEET 4 AA6 4 HIS C 104 TRP C 112 -1 O ALA C 109 N PHE C 97 SHEET 1 AA7 3 ARG C 126 TRP C 129 0 SHEET 2 AA7 3 ALA C 133 THR C 137 -1 O THR C 137 N ARG C 126 SHEET 3 AA7 3 ASN C 169 GLU C 173 -1 O ILE C 172 N VAL C 134 SHEET 1 AA8 5 GLN C 161 GLU C 165 0 SHEET 2 AA8 5 LEU C 146 ARG C 153 -1 N TYR C 148 O GLU C 165 SHEET 3 AA8 5 TYR C 181 ALA C 189 -1 O LYS C 188 N LEU C 147 SHEET 4 AA8 5 THR C 207 GLN C 210 -1 O TRP C 209 N TYR C 181 SHEET 5 AA8 5 GLU C 213 ARG C 215 -1 O ARG C 215 N CYS C 208 SSBOND 1 CYS A 34 CYS A 110 1555 1555 2.05 SSBOND 2 CYS A 69 CYS A 75 1555 1555 2.05 SSBOND 3 CYS A 90 CYS A 137 1555 1555 2.03 SSBOND 4 CYS B 42 CYS B 57 1555 1555 2.05 SSBOND 5 CYS B 74 CYS B 82 1555 1555 2.05 SSBOND 6 CYS B 108 CYS B 118 1555 1555 2.04 SSBOND 7 CYS C 71 CYS C 84 1555 1555 2.07 SSBOND 8 CYS C 138 CYS C 168 1555 1555 2.05 SSBOND 9 CYS C 180 CYS C 218 1555 1555 2.06 LINK ND2 ASN C 55 C1 NAG C 302 1555 1555 1.43 LINK ND2 ASN C 169 C1 NAG C 303 1555 1555 1.43 CRYST1 135.783 66.644 91.971 90.00 109.20 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007365 0.000000 0.002565 0.00000 SCALE2 0.000000 0.015005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011513 0.00000